LifeSci Capital initiated coverage of Kodiak Sciences (KOD) with an Outperform rating and $40 price target
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KOD:
- Kodiak Sciences upgraded to Equal Weight from Underweight at Barclays
- Pfizer to acquire Metsera, Oracle names new CEOs: Morning Buzz
- Promising Drug Pipeline and Strong Financial Position Drive Buy Rating for Kodiak Sciences
- Kodiak Sciences initiated with a Buy at Jefferies
- Kodiak Sciences announces new data from APEX study of KSI-101